In these studies, anti-CXCL10 antibody treatment ameliorated the severity of cystitis as determined with histological evaluation of urinary bladder and changes in leukocyte subpopulations and mast cells (Sakthivel et al., 2008; Singh et al., 2013). Here, CXCL10 is linked to chronic cystitis.